<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We are reporting a <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> patient with <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> who developed iliofemoral <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Before the occurrence of iliofemoral <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo>, <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> (aPL) gradually decreased over a period of 18 weeks but were within <z:mpath ids='MPATH_458'>normal</z:mpath> range during its <z:hpo ids='HP_0011009'>acute</z:hpo> phase </plain></SENT>
<SENT sid="2" pm="."><plain>In the course of two years following this case of <z:mp ids='MP_0005048'>thrombosis</z:mp>, aPL have never returned to the high prethrombotic values </plain></SENT>
<SENT sid="3" pm="."><plain>It is therefore most likely that aPL were involved in the process of provoking <z:mp ids='MP_0005048'>thrombosis</z:mp> rather than being consumed during its <z:hpo ids='HP_0011009'>acute</z:hpo> phase </plain></SENT>
</text></document>